Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases

Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases

Myelin oligodendrocyte glycoprotein (MOG), a member of the immunoglobulin (Ig) superfamily, is a myelin protein solely expressed at the outermost surface of myelin sheaths and oligodendrocyte membranes. This makes MOG a potential target of cellular and humoral immune responses in inflammatory demyel...

Full description

Bibliographic Details
Main Authors:	Patrick Peschl, Monika Bradl, Romana Höftberger, Thomas Berger, Markus Reindl
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-05-01
Series:	Frontiers in Immunology
Subjects:	myelin oligodendrocyte glycoprotein demyelination autoantibodies inflammation MOG
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.00529/full

Similar Items

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
by: Patrick Peschl, et al.
Published: (2017-10-01)

Case report: A patient with meningoencephalitis followed by asymptomatic anti-myelin oligodendrocyte glycoprotein antibody-related disorder
by: Yunjie Li, et al.
Published: (2022-09-01)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
by: Osman Corbali, et al.
Published: (2023-02-01)

Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
by: Shambaditya Das, et al.
Published: (2023-03-01)

Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
by: Kuniko Kohyama, et al.
Published: (2023-02-01)

Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
by: Jonathan D. Santoro, et al.
Published: (2023-04-01)

Clinical and Neuroimaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Min Zhang, et al.
Published: (2020-11-01)

High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting
by: Tammy L. Smith, et al.
Published: (2023-07-01)

Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
by: Jin Myoung Seok, et al.
Published: (2023-06-01)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Diseases in Children in Central South China: Clinical Features, Treatments, Influencing Factors, and Outcomes
by: Leilei Mao, et al.
Published: (2019-08-01)

Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously
by: Yijun Ren, et al.
Published: (2019-12-01)

Transverse myelitis in myelin oligodendrocyte glycoprotein antibody-associated disease
by: Gina Perez-Giraldo, et al.
Published: (2023-07-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
by: Wojciech Ambrosius, et al.
Published: (2020-12-01)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
by: Helen Cross, et al.
Published: (2021-01-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients
by: Sven Jarius, et al.
Published: (2020-09-01)

MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome
by: Sara Mariotto, et al.
Published: (2017-10-01)

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patients
by: Sven Jarius, et al.
Published: (2020-09-01)

Clinical characteristics of myelin-oligodendrocyte glycoprotein antibody-positive pediatric autoimmune encephalitis without demyelination: A case series
by: Xiaojie Song, et al.
Published: (2022-12-01)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
by: Mader Simone, et al.
Published: (2011-12-01)

Transient myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis following influenza A infection: A rare case
by: Prashant Nasa, et al.
Published: (2021-01-01)

Clinical characteristics and prognosis of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseases in China
by: Xiaoang Sun, et al.
Published: (2022-11-01)

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination
by: Fiona Tea, et al.
Published: (2019-09-01)

Myelin Oligodendrocyte Glycoprotein Antibody Associated Transverse Myelitis
by: Iveta Chroustová, et al.
Published: (2019-01-01)

New-onset epilepsy in a patient with myelin oligodendrocyte glycoprotein antibodies
by: Hansol Im, et al.
Published: (2021-04-01)

Myelin oligodendrocyte glycoprotein antibody titers by fixed cell-based assay: positive predictive value and impact of sample collection timing
by: Adrian Budhram, et al.
Published: (2024-03-01)

The Expanding Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Associated Disease in Children and Adults
by: Erica Parrotta, et al.
Published: (2020-09-01)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
by: Livia Sophie Hofer, et al.
Published: (2020-06-01)

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders
by: Masoud Etemadifar, et al.
Published: (2017-10-01)

Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report
by: Jan Kolcava, et al.
Published: (2022-08-01)

Myelin oligodendrocyte glycoprotein antibody-associated disorders: clinical spectrum, diagnostic evaluation, and treatment options
by: Yun-Jin Lee, et al.
Published: (2021-03-01)

Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide
by: Jyh Yung Hor, et al.
Published: (2023-09-01)

Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor
by: Ilaria Cervellini, et al.
Published: (2013-06-01)

Phenotypic characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease in children: a single-center, retrospective study
by: Yi Hua, et al.
Published: (2023-08-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorders: Toward a New Spectrum of Inflammatory Demyelinating CNS Disorders?
by: Franziska Di Pauli, et al.
Published: (2018-11-01)

Clinical and Magnetic Resonance Imaging Characteristics of Pediatric Acute Disseminating Encephalomyelitis With and Without Antibodies to Myelin Oligodendrocyte Glycoprotein
by: Meifang Lei, et al.
Published: (2022-05-01)

Comparison of glial fibrillary acidic protein-immunoglobulin G-associated myelitis with myelin oligodendrocyte glycoprotein-immunoglobulin G-associated myelitis
by: Mengyang Sun, et al.
Published: (2023-10-01)

Anti-myelin oligodendrocyte glycoprotein antibody-positive coursing with optic neuritis: Imaging and clinical implications
by: Nithisha Thatikonda, et al.
Published: (2020-04-01)

The Clinical, Radiologic, and Prognostic Differences Between Pediatric and Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis
by: Jie Xu, et al.
Published: (2021-05-01)

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and Human Immunodeficiency virus infection: dilemmas in diagnosis and management: a case series
by: Yohane Gadama, et al.
Published: (2023-10-01)

The organization of microtubules and Tau in oligodendrocytes: Tau pathology in damaged oligodendrocytes
by: Tomohiro Torii, et al.
Published: (2022-10-01)